dr. T.J.N. Hiltermann

Research
Publications
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity
van den Broek, D., Hiltermann, T. J. N., Biesma, B., Dinjens, W. N. M., 't Hart, N. A., Hinrichs, J. W. J., Leers, M. P. G., Monkhorst, K., van Oosterhout, M., Scharnhorst, V., Schuuring, E., Speel, E-J. M., van den Heuvel, M. M., van Schaik, R. H. N., von der Thüsen, J., Willems, S. M., de Visser, L. & Ligtenberg, M. J. L., 2019, In : Frontiers in Oncology. 9, p. 1521Research output: Contribution to journal › Review article › Academic › peer-review
Treatment goals and changes over time in older patients with non-curable cancer
Stegmann, M. E., Brandenbarg, D., Reyners, A. K. L., van Geffen, W. H., Hiltermann, T. J. N. & Berendsen, A. J., 22-Dec-2020, In : Supportive Care in Cancer. 8 p.Research output: Contribution to journal › Article › Academic › peer-review
Dutch Oncology COVID-19 consortium: Outcome of COVID-19 in patients with cancer in a nationwide cohort study
DOCC Investigators, de Joode, K., Tol, J., Westgeest, H. M., Beerepoot, L. V., van den Berkmortel, F. W. P. J., Mutsaers, P. G. N. J., van Diemen, N. G. J., Visser, O. J., Oomen-de Hoop, E., Bloemendal, H. J., van Laarhoven, H. W. M., Hendriks, L. E. L., Haanen, J. B. A. G., de Vries, E. G. E., Dingemans, A. M. C. & van der Veldt, A. A. M., Dec-2020, In : European Journal of Cancer. 141, p. 171-184 14 p.Research output: Contribution to journal › Article › Academic › peer-review
The clinical effect of concurrent oncogenic gene mutations in BRAF p.(V600E)-mutated NSCLC treated with dabrafenib and trametinib
Meng, P., Koopman, B., Kok, K., ter Elst, A., Schuuring, E., van Kempen, L. C., Timens, W., Hiltermann, T. J. N., Groen, H. J. M., van den Berg, A. & van der Wekken, A. J., Sep-2020, In : Annals of Oncology. 31, p. S1106-S1106 1 p.Research output: Contribution to journal › Meeting Abstract › Academic
An All-In-One Transcriptome-Based Assay to Identify Therapy-Guiding Genomic Aberrations in Nonsmall Cell Lung Cancer Patients
Wei, J., Rybczynska, A. A., Meng, P., Terpstra, M., Saber, A., Sietzema, J., Timens, W., Schuuring, E., Hiltermann, T. J. N., Groen, H. J. M., van der Wekken, A. J., van den Berg, A. & Kok, K., Oct-2020, In : Cancers. 12, 10, p. 1-17 18 p., 2843.Research output: Contribution to journal › Article › Academic › peer-review
Activities
Treatment, pharmacological and non-pharmacological of lung cancer
Jeroen Hiltermann (Invited speaker)
22-Jun-2018Activity: Talk or presentation › Professional
Behandeling van Immunotherapie gerelateerde bijwerkingen met nadruk op de immuun gerelateerde pneumonitis
Jeroen Hiltermann (Invited speaker)
18-Sep-2018Activity: Talk or presentation › Professional
WCLC Toronto 2019
Jeroen Hiltermann (Participant)
22-Sep-2018 → 29-Sep-2018Activity: Participating in or organising an event › Participation in conference › Professional
ID: 403191